Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.

Honda K, Ono M, Shitashige M, Masuda M, Kamita M, Miura N, Yamada T.

Jpn J Clin Oncol. 2013 Feb;43(2):103-9. doi: 10.1093/jjco/hys200. Epub 2012 Dec 16. Review.

PMID:
23248327
2.

Altered plasma apolipoprotein modifications in patients with pancreatic cancer: protein characterization and multi-institutional validation.

Honda K, Okusaka T, Felix K, Nakamori S, Sata N, Nagai H, Ioka T, Tsuchida A, Shimahara T, Shimahara M, Yasunami Y, Kuwabara H, Sakuma T, Otsuka Y, Ota N, Shitashige M, Kosuge T, Büchler MW, Yamada T.

PLoS One. 2012;7(10):e46908. doi: 10.1371/journal.pone.0046908. Epub 2012 Oct 8.

3.

CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation.

Kashima L, Idogawa M, Mita H, Shitashige M, Yamada T, Ogi K, Suzuki H, Toyota M, Ariga H, Sasaki Y, Tokino T.

J Biol Chem. 2012 Apr 13;287(16):12975-84. doi: 10.1074/jbc.M111.321828. Epub 2012 Feb 15.

4.

β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.

Satow R, Shitashige M, Jigami T, Fukami K, Honda K, Kitabayashi I, Yamada T.

Gastroenterology. 2012 Mar;142(3):572-81. doi: 10.1053/j.gastro.2011.11.041. Epub 2011 Dec 9.

PMID:
22155184
5.

Combined functional genome survey of therapeutic targets for clear cell carcinoma of the kidney.

Ito H, Honda K, Satow R, Arai E, Shitashige M, Ono M, Sakuma T, Sakano S, Naito K, Matsuyama H, Yamada T.

Jpn J Clin Oncol. 2011 Jul;41(7):847-53. doi: 10.1093/jjco/hyr060. Epub 2011 May 15.

PMID:
21576114
6.

Traf2- and Nck-interacting kinase is essential for canonical Wnt signaling in Xenopus axis formation.

Satow R, Shitashige M, Jigami T, Honda K, Ono M, Hirohashi S, Yamada T.

J Biol Chem. 2010 Aug 20;285(34):26289-94. doi: 10.1074/jbc.M109.090597. Epub 2010 Jun 21.

7.

Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.

Shitashige M, Satow R, Jigami T, Aoki K, Honda K, Shibata T, Ono M, Hirohashi S, Yamada T.

Cancer Res. 2010 Jun 15;70(12):5024-33. doi: 10.1158/0008-5472.CAN-10-0306. Epub 2010 Jun 8.

8.

Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.

Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, Yamada T.

Clin Cancer Res. 2010 May 1;16(9):2518-28. doi: 10.1158/1078-0432.CCR-09-2214. Epub 2010 Apr 13.

9.

Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma.

Kobayashi E, Masuda M, Nakayama R, Ichikawa H, Satow R, Shitashige M, Honda K, Yamaguchi U, Shoji A, Tochigi N, Morioka H, Toyama Y, Hirohashi S, Kawai A, Yamada T.

Mol Cancer Ther. 2010 Mar;9(3):535-44. doi: 10.1158/1535-7163.MCT-09-0774. Epub 2010 Feb 16.

10.

Functional genome screen for therapeutic targets of osteosarcoma.

Yamaguchi U, Honda K, Satow R, Kobayashi E, Nakayama R, Ichikawa H, Shoji A, Shitashige M, Masuda M, Kawai A, Chuman H, Iwamoto Y, Hirohashi S, Yamada T.

Cancer Sci. 2009 Dec;100(12):2268-74. doi: 10.1111/j.1349-7006.2009.01310.x. Epub 2009 Aug 10.

11.

Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma.

Negishi A, Masuda M, Ono M, Honda K, Shitashige M, Satow R, Sakuma T, Kuwabara H, Nakanishi Y, Kanai Y, Omura K, Hirohashi S, Yamada T.

Cancer Sci. 2009 Sep;100(9):1605-11. doi: 10.1111/j.1349-7006.2009.01227.x. Epub 2009 May 18.

12.

Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry.

Negishi A, Ono M, Handa Y, Kato H, Yamashita K, Honda K, Shitashige M, Satow R, Sakuma T, Kuwabara H, Omura K, Hirohashi S, Yamada T.

Cancer Sci. 2009 Mar;100(3):514-9. doi: 10.1111/j.1349-7006.2008.01055.x. Epub 2008 Dec 19.

13.

Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas.

Kikuchi S, Honda K, Tsuda H, Hiraoka N, Imoto I, Kosuge T, Umaki T, Onozato K, Shitashige M, Yamaguchi U, Ono M, Tsuchida A, Aoki T, Inazawa J, Hirohashi S, Yamada T.

Clin Cancer Res. 2008 Sep 1;14(17):5348-56. doi: 10.1158/1078-0432.CCR-08-0075.

14.

Distinct gene expression-defined classes of gastrointestinal stromal tumor.

Yamaguchi U, Nakayama R, Honda K, Ichikawa H, Hasegawa T, Shitashige M, Ono M, Shoji A, Sakuma T, Kuwabara H, Shimada Y, Sasako M, Shimoda T, Kawai A, Hirohashi S, Yamada T.

J Clin Oncol. 2008 Sep 1;26(25):4100-8. doi: 10.1200/JCO.2007.14.2331.

PMID:
18757323
15.

Regulation of Wnt signaling by the nuclear pore complex.

Shitashige M, Satow R, Honda K, Ono M, Hirohashi S, Yamada T.

Gastroenterology. 2008 Jun;134(7):1961-71, 1971.e1-4. doi: 10.1053/j.gastro.2008.03.010. Epub 2008 Mar 10.

PMID:
18439914
16.

Wnt signaling inside the nucleus.

Shitashige M, Hirohashi S, Yamada T.

Cancer Sci. 2008 Apr;99(4):631-7. doi: 10.1111/j.1349-7006.2007.00716.x. Epub 2008 Jan 2. Review.

17.

Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.

Huang L, Shitashige M, Satow R, Honda K, Ono M, Yun J, Tomida A, Tsuruo T, Hirohashi S, Yamada T.

Gastroenterology. 2007 Nov;133(5):1569-78. Epub 2007 Aug 6.

PMID:
17983804
18.

Increased susceptibility of Sf1(+/-) mice to azoxymethane-induced colon tumorigenesis.

Shitashige M, Satow R, Honda K, Ono M, Hirohashi S, Yamada T.

Cancer Sci. 2007 Dec;98(12):1862-7. Epub 2007 Sep 26.

19.

Serum albumin-associated peptides of patients with uterine endometrial cancer.

Kikuchi S, Honda K, Handa Y, Kato H, Yamashita K, Umaki T, Shitashige M, Ono M, Tsuchida A, Aoki T, Hirohashi S, Yamada T.

Cancer Sci. 2007 Jun;98(6):822-9. Epub 2007 Apr 5.

20.

Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.

Shitashige M, Naishiro Y, Idogawa M, Honda K, Ono M, Hirohashi S, Yamada T.

Gastroenterology. 2007 Mar;132(3):1039-54. Epub 2007 Jan 5.

PMID:
17383426
21.

Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling.

Idogawa M, Masutani M, Shitashige M, Honda K, Tokino T, Shinomura Y, Imai K, Hirohashi S, Yamada T.

Cancer Res. 2007 Feb 1;67(3):911-8.

22.

Mass spectrometry analysis of the native protein complex containing actinin-4 in prostate cancer cells.

Hara T, Honda K, Shitashige M, Ono M, Matsuyama H, Naito K, Hirohashi S, Yamada T.

Mol Cell Proteomics. 2007 Mar;6(3):479-91. Epub 2006 Dec 6.

23.

[Early detection of pancreatic cancer by novel proteomic technique].

Honda K, Ono M, Shitashige M, Yamada T.

Nihon Rinsho. 2006 Sep;64(9):1745-55. Review. Japanese.

PMID:
16972690
24.

Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry.

Ono M, Shitashige M, Honda K, Isobe T, Kuwabara H, Matsuzuki H, Hirohashi S, Yamada T.

Mol Cell Proteomics. 2006 Jul;5(7):1338-47. Epub 2006 Mar 21.

25.

Enhancement by cyclosporin A of taxol-induced apoptosis of human urinary bladder cancer cells.

Nomura T, Yamamoto H, Mimata H, Shitashige M, Shibasaki F, Miyamoto E, Nomura Y.

Urol Res. 2002 May;30(2):102-11.

PMID:
12086014
26.

Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.

Noguchi K, Shitashige M, Endo H, Kondo H, Ishikawa I.

J Periodontal Res. 2002 Feb;37(1):29-36.

PMID:
11842936
27.

Dissociation of Bax from a Bcl-2/Bax heterodimer triggered by phosphorylation of serine 70 of Bcl-2.

Shitashige M, Toi M, Yano T, Shibata M, Matsuo Y, Shibasaki F.

J Biochem. 2001 Dec;130(6):741-8.

28.

Involvement of cyclooxygenase-2 in serum-induced prostaglandin production by human oral gingival epithelial cells.

Noguchi K, Shitashige M, Endo H, Kondo H, Yotsumoto Y, Izumi Y, Nitta H, Ishikawa I.

J Periodontal Res. 2001 Apr;36(2):124-30.

PMID:
11327079
29.

Downregulation of lipopolysaccharide-induced intercellular adhesion molecule-1 expression via EP2/EP4 receptors by prostaglandin E2 in human fibroblasts.

Noguchi K, Iwasaki K, Shitashige M, Umeda M, Izumi Y, Murota S, Ishikawa I.

Inflammation. 2001 Apr;25(2):75-81.

PMID:
11321362
30.
31.

Prostaglandins E2 and I2 downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human oral gingival epithelial cells.

Noguchi K, Iwasaki K, Endo H, Kondo H, Shitashige M, Ishikawa I.

Oral Microbiol Immunol. 2000 Oct;15(5):299-304.

PMID:
11154420
32.
34.

Existence of endogenous inhibitor(s) of prostaglandin endoperoxide H synthase activities in murine NIH3T3 fibroblasts.

Shitashige M, Morita I, Murota S.

Prostaglandins Leukot Essent Fatty Acids. 1999 Aug;61(2):97-103.

PMID:
10509864
35.
36.
37.

Interleukin-4 and interferon-gamma inhibit prostaglandin production by interleukin-1beta-stimulated human periodontal ligament fibroblasts.

Noguchi K, Shitashige M, Watanabe H, Murota S, Ishikawa I.

Inflammation. 1999 Feb;23(1):1-13.

PMID:
10065757
38.

[The role of calcineurin in Ca(2+)-mediated apoptosis].

Shitashige M, Shibasaki F.

Tanpakushitsu Kakusan Koso. 1998 Sep;43(12 Suppl):1877-83. Review. Japanese. No abstract available.

PMID:
9788196
39.

Cationic amino acid transporter-2 mRNA induction by tumor necrosis factor-alpha in vascular endothelial cells.

Irie K, Tsukahara F, Fujii E, Uchida Y, Yoshioka T, He WR, Shitashige M, Murota S, Muraki T.

Eur J Pharmacol. 1997 Nov 27;339(2-3):289-93.

PMID:
9473147
40.

Different substrate utilization between prostaglandin endoperoxide H synthase-1 and -2 in NIH3T3 fibroblasts.

Shitashige M, Morita I, Murota S.

Biochim Biophys Acta. 1998 Jan 5;1389(1):57-66.

PMID:
9443604
41.

Prostaglandin production via induction of cyclooxygenase-2 by human gingival fibroblasts stimulated with lipopolysaccharides.

Noguchi K, Shitashige M, Yanai M, Morita I, Nishihara T, Murota S, Ishikawa I.

Inflammation. 1996 Oct;20(5):555-68.

PMID:
8894718
42.
43.

Oxidative modification of low density lipoprotein by diesel exhaust particles.

Ikeda M, Shitashige M, Yamasaki H, Sagai M, Tomita T.

Biol Pharm Bull. 1995 Jun;18(6):866-71.

PMID:
7550122
44.

A novel ubiquinone reductase activity in rat cytosol.

Takahashi T, Shitashige M, Okamoto T, Kishi T, Goshima K.

FEBS Lett. 1992 Dec 21;314(3):331-4.

Supplemental Content

Loading ...
Support Center